Document Detail


Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration.
MedLine Citation:
PMID:  9056049     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: The purpose of this study was to investigate the effect of activated charcoal on the absorption of amlodipine, with special reference to delayed charcoal administration. METHODS: Thirty-two healthy volunteers, eight subjects in four parallel groups, ingested 10 mg of amlodipine on an empty stomach. Activated charcoal (25 g in 300 ml of water) was ingested either immediately afterwards or 2 h or 6 h after amlodipine, or amlodipine was ingested with 300 ml of water only (control). Plasma concentrations and the cumulative excretion of amlodipine into urine were measured by GC-MS for 96 h and 72 h, respectively. In addition, adsorption of amlodipine to charcoal was studied in vitro. RESULTS: Activated charcoal administered immediately after amlodipine reduced the amlodipine AUC(0.96 h) and the 72-h urinary excretion by 99% (P < 0.0005). After a delay of 2 h in charcoal administration the AUC(0.96 h) was reduced by 49% (P = 0.001), but after a delay of 6 h the reduction was 15% only (P = NS). At a charcoal:drug ratio of 5:1, about 90% of amlodipine was adsorbed by charcoal in vitro; at ratios of 10:1 and 20:1, adsorption was practically complete. CONCLUSIONS: Activated charcoal almost completely prevented amlodipine absorption when administered immediately after amlodipine ingestion. Charcoal also markedly reduced amlodipine absorption when given 2 h after amlodipine; in amlodipine overdose, administration of charcoal may be beneficial even later. We conclude that administration of activated charcoal is the method of choice to prevent absorption of amlodipine in amlodipine overdose.
Authors:
K Laine; K T Kivistö; I Laakso; P J Neuvonen
Related Documents :
10658549 - Preventing commercial fishing deaths in alaska.
21340729 - Risk factors for severe retinopathy of prematurity in preterm low birth weight neonates.
21514859 - Neurological examination of late-preterm infants at term age.
22214879 - Electrophysiological measurements and analysis of nociception in human infants.
6997179 - Glucocorticoids in prevention of respiratory distress syndrome.
2998859 - Lithium suppresses hibernation in the turkish hamster.
2299439 - Married mothers' perceptions of their premature or term infants and the quality of thei...
15342829 - Perinatal stroke in children with motor impairment: a population-based study.
14648519 - Case report of a pressure ulcer in an infant receiving extracorporeal life support: the...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  43     ISSN:  0306-5251     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  1997 Jan 
Date Detail:
Created Date:  1997-05-29     Completed Date:  1997-05-29     Revised Date:  2009-10-02    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  29-33     Citation Subset:  IM    
Affiliation:
Department of Pharmacology and Clinical Pharmacology, University of Turku, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adsorption / drug effects
Adult
Amlodipine / adverse effects,  pharmacokinetics*
Analysis of Variance
Calcium Channel Blockers / adverse effects,  pharmacokinetics*
Charcoal / administration & dosage*
Female
Humans
Intestinal Absorption*
Male
Overdose / prevention & control
Chemical
Reg. No./Substance:
0/Calcium Channel Blockers; 16291-96-6/Charcoal; 88150-42-9/Amlodipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of the pharmacokinetics of lamotrigine in patients with chronic renal failure and healthy...
Next Document:  Meloxicam pharmacokinetics in renal impairment.